Also, the risk of lymph node metastasis of lung adenocarcinoma was lower likely with the CA9 SNP rs2071676 AG + GG in the EGFR wild type group (p = 0.005). This evidence concerns the gene CA9 and metastatic malignant neoplasm in the lymph nodes.